Hegen Li
Impact in
-
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 9
- Ferroptosis and cancer prognosis 4
- Oncology 15
- Lung Cancer Research Studies 6
- Co-authors
- Jianhui Tian (13 shared papers)Yi Jiang (8 shared papers)Jiaxiang Liu (6 shared papers)Wei Huang (2 shared papers)Deyue Yan (2 shared papers)Zhu-Jun Mao (3 shared papers)Lingshuang Liu (5 shared papers)Mo Sun (1 shared paper)
- Journals
- Journal of Ethnopharmacology (3 papers)Journal of Integrative Medicine (3 papers)Materials & Design (2 papers)BMC Complementary and Alternative Medicine (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaNorwayUnited States
In The Last Decade
Hegen Li
38 papers receiving 637 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 109
- Biomaterials 94
- Oncology 190
- Complementary and alternative medicine 42
- Pulmonary and Respiratory Medicine 159
Countries citing papers authored by Hegen Li
This map shows the geographic impact of Hegen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hegen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hegen Li more than expected).
Fields of papers citing papers by Hegen Li
This network shows the impact of papers produced by Hegen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hegen Li. The network helps show where Hegen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hegen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 117 | |
| 2 | 2015 | 70 | |
| 3 | 2017 | 55 | |
| 4 | 2012 | 34 | |
| 5 | 2021 | 30 | |
| 6 | 2020 | 27 | |
| 7 | 2014 | 26 | |
| 8 | 2019 | 25 | |
| 9 | 2019 | 23 | |
| 10 | 2017 | 23 | |
| 11 | 2021 | 22 | |
| 12 | 2018 | 17 | |
| 13 | 2023 | 16 | |
| 14 | 2019 | 16 | |
| 15 | 2001 | 13 | |
| 16 | 2021 | 12 | |
| 17 | 2020 | 12 | |
| 18 | 2024 | 11 | |
| 19 | 2022 | 11 | |
| 20 | 2024 | 10 |
About Hegen Li
Hegen Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Epidemiology, having authored 44 papers that have together received 653 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Research Studies (6 papers), Nanoplatforms for cancer theranostics (5 papers), Ferroptosis and cancer prognosis (4 papers), Mycobacterium research and diagnosis (4 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Cancer Research (109 citations), Biomaterials (94 citations), Oncology (190 citations), Complementary and alternative medicine (42 citations) and Pulmonary and Respiratory Medicine (159 citations). Hegen Li has collaborated with scholars based in China, Norway and United States. Frequent co-authors include Jianhui Tian, Yi Jiang, Jiaxiang Liu, Wei Huang, Deyue Yan, Zhu-Jun Mao, Lingshuang Liu, Mo Sun, Xinyuan Zhu and Zujun Que. Their work appears in journals such as Journal of Ethnopharmacology, Journal of Integrative Medicine, Materials & Design, BMC Complementary and Alternative Medicine and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.